An assessment of anxiolytic drug screening tests: Hormetic dose responses predominate

被引:102
作者
Calabrese, Edward J. [1 ]
机构
[1] Univ Massachusetts, Sch Publ Hlth & Hlth Sci Environm Hlth Sci, Dept Publ Hlth, Amherst, MA 01003 USA
关键词
anxiety; anxiolytic; biphasic; conflict test; depression; dose-response; elevated plus maze test; forced swimming test; four plates test; GABA; hole board test; hormesis; light-dark test; open field test; partial agonist; social interaction test; staircase test; stress; tail suspension test; ulcer; U-shaped;
D O I
10.1080/10408440802014238
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
This article provides a comprehensive assessment of dose response relationships for anxiolytic (i.e., anxiety-reducing) agents within a broad representation of the animal model screening tests. These screening tests include the elevated plus maze test, light-dark test, hole board test, open field test, four plates test, social interaction test, Vogel's conflict test, staircase test, freeze behavior test, forced swimming test, tail suspension test, communication box test, and immobilization/cold stress test. The analysis revealed that hormetic-like biphasic dose responses were commonly observed across all screening tests, independent of the animal model, the conditions of the test, modifications of tests by investigators, and the chemical class of agents tested. The quantitative features of the dose response, as measured by the magnitude and width of the stimulation at low doses, were similar across all screening tests and experimental conditions, regardless of the mechanism and receptor activation pathway identified. These findings, which add more support to the perspective that the hormetic dose response represents the most fundamental and common dose-response model in the biomedical and toxicological sciences, have important implications for the process of drug discovery/development, clinical evaluation, and quantitative expectation of drug treatment effects.
引用
收藏
页码:489 / 542
页数:54
相关论文
共 323 条
[1]
5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex [J].
Abi-Saab, WM ;
Bubser, M ;
Roth, RH ;
Deutch, AY .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (01) :92-96
[2]
ALLAN AM, 1986, J PHARMACOL EXP THER, V238, P763
[3]
[Anonymous], PSYCHOPHARMACOLOGY B
[4]
Araujo Joao Eduardo De, 1998, Experimental Brain Research, V123, P84
[5]
Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder [J].
Arnsten, Amy F. T. ;
Dudley, Anne G. .
BEHAVIORAL AND BRAIN FUNCTIONS, 2005, 1 (1)
[6]
EVALUATION OF RAPID TECHNIQUE FOR DETECTING MINOR TRANQUILIZERS [J].
ARON, C ;
SIMON, P ;
LAROUSSE, C ;
BOISSIER, JR .
NEUROPHARMACOLOGY, 1971, 10 (04) :459-&
[7]
THE PHARMACOLOGY OF VA21B7 - AN ATYPICAL 5-HT3 RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE PROPERTIES IN ANIMAL-MODELS [J].
ARTAIZ, I ;
ROMERO, G ;
ZAZPE, A ;
MONGE, A ;
CALDERO, JM ;
ROCA, J ;
LASHERAS, B ;
DELRIO, J .
PSYCHOPHARMACOLOGY, 1995, 117 (02) :137-148
[8]
Intra- and interstrain differences in models of "behavioral despair" [J].
Bai, F ;
Li, X ;
Clay, M ;
Lindstrom, T ;
Skolnick, P .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (2-3) :187-192
[9]
ANTAGONISTIC EFFECTS OF CAFFEINE AND YOHIMBINE IN ANIMAL TESTS OF ANXIETY [J].
BALDWIN, HA ;
JOHNSTON, AL ;
FILE, SE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 159 (02) :211-215
[10]
Baumann SW, 2003, J NEUROSCI, V23, P11158